metastatic pancreatic adenocarcinoma
Showing 1 - 25 of 71
Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Bendamustine
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 12, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ascorbate
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Devimistat
- Modified FOLFIRINOX
-
Ann Arbor, MichiganRogel Cancer Center
Jun 26, 2023
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +5 more
- Anetumab Ravtansine
- +5 more
-
Birmingham, Alabama
- +44 more
Feb 2, 2023
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Olaparib, Pembrolizumab)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Olaparib
- Pembrolizumab
-
Anchorage, Alaska
- +513 more
Jan 28, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Irinotecan liposome injection
- +2 more
-
Bedford Park, Australia
- +35 more
Jan 24, 2023
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Avelumab and Pepinemab
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 19, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in United States (Gemcitabine combined with
Recruiting
- Metastatic Pancreatic Cancer
- Metastatic Pancreatic Adenocarcinoma
- Gemcitabine combined with nab-paclitaxel
- +4 more
-
La Jolla, California
- +20 more
Aug 18, 2022
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Nivolumab (Cohort A)
- +4 more
-
Los Angeles, California
- +6 more
Aug 8, 2022
Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- odetiglucan
- CDX-1140
- (no location specified)
Jul 29, 2022
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Biopsy
- +4 more
-
Chicago, Illinois
- +11 more
Jun 28, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)
Terminated
- Metastatic Pancreatic Adenocarcinoma
- Regorafenib
- Gemcitabine Hydrochloride
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Fluorouracil
- +8 more
-
Boise, Idaho
- +42 more
Jun 8, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
- VLP-encapsulated TLR9 Agonist CMP-001
-
Scottsdale, Arizona
- +3 more
Jun 1, 2022